Header Logo

Connection

THOMAS KOSTEN to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications THOMAS KOSTEN has written about Clinical Trials as Topic.
THOMAS KOSTEN
Connection Strength
1.211
Clinical Trials as Topic
  1. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers. Am J Addict. 2002; 11(2):111-23.
    View in: PubMed
    Score: 0.131
  2. Current status and future prospects for the development of substance abuse vaccines. Expert Rev Vaccines. 2017 11; 16(11):1067-1077.
    View in: PubMed
    Score: 0.097
  3. Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy. Expert Opin Emerg Drugs. 2015 Mar; 20(1):15-29.
    View in: PubMed
    Score: 0.080
  4. The future potential for cocaine vaccines. Expert Opin Biol Ther. 2014 Sep; 14(9):1271-83.
    View in: PubMed
    Score: 0.077
  5. Vaccines against stimulants: cocaine and MA. Br J Clin Pharmacol. 2014 Feb; 77(2):368-74.
    View in: PubMed
    Score: 0.076
  6. Pharmacotherapy for stimulant-related disorders. Curr Psychiatry Rep. 2013 Nov; 15(11):415.
    View in: PubMed
    Score: 0.074
  7. Vaccines against drug abuse. Clin Pharmacol Ther. 2012 Jan; 91(1):60-70.
    View in: PubMed
    Score: 0.065
  8. Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med. 2011 Nov 03; 9:119.
    View in: PubMed
    Score: 0.065
  9. The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Neuropsychopharmacology. 2012 Jan; 37(2):402-11.
    View in: PubMed
    Score: 0.064
  10. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother. 2009 Aug; 10(11):1727-40.
    View in: PubMed
    Score: 0.055
  11. Substance abuse vaccines. Ann N Y Acad Sci. 2008 Oct; 1141:257-69.
    View in: PubMed
    Score: 0.052
  12. The future of vaccines in the management of addictive disorders. Curr Psychiatry Rep. 2007 Oct; 9(5):381-7.
    View in: PubMed
    Score: 0.049
  13. Therapeutic vaccines for substance dependence. Expert Rev Vaccines. 2004 Feb; 3(1):11-8.
    View in: PubMed
    Score: 0.038
  14. Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. JAMA Psychiatry. 2023 01 01; 80(1):84-92.
    View in: PubMed
    Score: 0.035
  15. The potential of dopamine agonists in drug addiction. Expert Opin Investig Drugs. 2002 Apr; 11(4):491-9.
    View in: PubMed
    Score: 0.033
  16. Current concepts in pharmacotherapy of substance abuse. Curr Psychiatry Rep. 1999 Dec; 1(2):172-8.
    View in: PubMed
    Score: 0.028
  17. Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis. 1998 Dec; 186(12):737-45.
    View in: PubMed
    Score: 0.026
  18. Rapid and ultrarapid opioid detoxification techniques. JAMA. 1998 Jan 21; 279(3):229-34.
    View in: PubMed
    Score: 0.025
  19. Examining the utility of using genotype and functional biology in a clinical pharmacology trial: pilot testing dopamine ?-hydroxylase, norepinephrine, and post-traumatic stress disorder. Psychiatr Genet. 2014 Aug; 24(4):181-2.
    View in: PubMed
    Score: 0.020
  20. Clinical and research perspectives on cocaine abuse: the pharmacotherapy of cocaine abuse. NIDA Res Monogr. 1993; 135:48-56.
    View in: PubMed
    Score: 0.018
  21. Buprenorphine for cocaine and opiate dependence. Psychopharmacol Bull. 1992; 28(1):15-9.
    View in: PubMed
    Score: 0.016
  22. Anti-cocaine vaccine development. Expert Rev Vaccines. 2010 Sep; 9(9):1109-14.
    View in: PubMed
    Score: 0.015
  23. Rapid detoxification from opioid dependence. Am J Psychiatry. 1989 Oct; 146(10):1349.
    View in: PubMed
    Score: 0.014
  24. Buprenorphine detoxification from opioid dependence: a pilot study. Life Sci. 1988; 42(6):635-41.
    View in: PubMed
    Score: 0.012
  25. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007 Jan 16; 146(2):116-27.
    View in: PubMed
    Score: 0.012
  26. Treatment of severe lithium-induced polyuria with amiloride. Am J Psychiatry. 1986 Dec; 143(12):1563-8.
    View in: PubMed
    Score: 0.012
  27. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts. Am J Drug Alcohol Abuse. 1985; 11(1-2):1-10.
    View in: PubMed
    Score: 0.010
  28. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry. 1989 Feb; 46(2):117-21.
    View in: PubMed
    Score: 0.003
  29. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry. 1988 Oct; 145(10):1289-91.
    View in: PubMed
    Score: 0.003
  30. Nontolerance to the opioid antagonism of naltrexone. Biol Psychiatry. 1985 Jan; 20(1):66-72.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.